Peginesatide Acetate Patent Expiration
Peginesatide Acetate is Used for managing anemia associated with chronic kidney disease. It was first introduced by Takeda Pharmaceuticals Usa Inc
Peginesatide Acetate Patents
Given below is the list of patents protecting Peginesatide Acetate, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Omontys | US7084245 | Peptides that bind to the erythropoietin receptor |
May 12, 2024
(Expired) | Takeda Pharms Usa |
Omontys | US7414105 | Peptides that bind to the erythropoietin receptor |
May 12, 2024
(Expired) | Takeda Pharms Usa |
Omontys | US7528104 | Peptides that bind to the erythropoietin receptor |
May 12, 2024
(Expired) | Takeda Pharms Usa |
Omontys | US7550433 | Erythropoietin receptor peptide formulations and uses | Jun 02, 2026 | Takeda Pharms Usa |
Omontys | US7919118 | Spacer moiety for poly (ethylene glycol) modified peptide based compounds |
May 12, 2024
(Expired) | Takeda Pharms Usa |
Omontys | US7919461 | Erythropoietin receptor peptide formulations and uses | Jun 02, 2026 | Takeda Pharms Usa |
Omontys Preservative Free | US7084245 | Peptides that bind to the erythropoietin receptor |
May 12, 2024
(Expired) | Takeda Pharms Usa |
Omontys Preservative Free | US7414105 | Peptides that bind to the erythropoietin receptor |
May 12, 2024
(Expired) | Takeda Pharms Usa |
Omontys Preservative Free | US7528104 | Peptides that bind to the erythropoietin receptor |
May 12, 2024
(Expired) | Takeda Pharms Usa |
Omontys Preservative Free | US7550433 | Erythropoietin receptor peptide formulations and uses | Jun 02, 2026 | Takeda Pharms Usa |
Omontys Preservative Free | US7919118 | Spacer moiety for poly (ethylene glycol) modified peptide based compounds |
May 12, 2024
(Expired) | Takeda Pharms Usa |
Omontys Preservative Free | US7919461 | Erythropoietin receptor peptide formulations and uses | Jun 02, 2026 | Takeda Pharms Usa |
Coming Soon
Patent Strength Analyzer
![](/_nuxt/img/PatentAnalyzerAd.722976d.jpg)
YesNo
Thank you for your response 🥳